The largest database of trusted experimental protocols
> Chemicals & Drugs > Antibiotic > Ampicillin

Ampicillin

Ampicillin is a broad-spectrum, semi-synthetic penicillin antibiotic effective against a wide range of gram-positive and gram-negative bacteria.
It is commonly used to treat infections caused by susceptible organisms, such as pneumonia, meningitis, gonorrhea, and urinary tract infections.
Ampicillin works by interfering with the synthesis of the bacterial cell wall, leading to cell lysis and death.
Researchers can optimize their Ampicillin studies using PubCompare.ai, an AI-driven platform that enhances reproducibility and accuracy.
The tool enables researchers to easily locate protocols from literature, preprints, and patents using advanced search capabilities, and leverage AI-driven comparisons to identify the best protocols and products for their Ampiclllin research.
This improves the effeciency and quality of Ampicillin studies, supporting more robust and reliable findings.

Most cited protocols related to «Ampicillin»

Cells were routinely grown in LB medium containing 1% Bacto Tryptone (Difco), 0.5% yeast extract (Difco), and 0.5% NaCl with or without antibiotics at 50 μg/ml for ampicillin (Wako, Osaka, Japan) and 30 μg/ml for kanamycin (Wako, Osaka, Japan). Glucose, L-arabinose, and other chemicals were from Wako (Osaka, Japan). DpnI was from New England Biolabs (MA, USA); Taq polymerase, TaKaRa Ex Taq, and agarose, SeaKem GTG Agarose from Takara Shuzo Inc. E-Gel 96 systems were from Invitrogen. MOPS medium was prepared as described elsewhere (Wanner, 1994 ).
Publication 2006
Ampicillin Antibiotics, Antitubercular Arabinose Cells Glucose Kanamycin morpholinopropane sulfonic acid Sepharose Sodium Chloride Taq Polymerase Yeast, Dried
The second dataset, published by Holt et al. [24 (link)], consists of 130 globally distributed genomes of Shigella sonnei (Table S2), a Gram-negative bacterium that is a causative agent of dysentery. It enabled a comparison of ARIBA, SRST2, and KmerResistance with the manual method employed in the study of Holt et al. [24 (link)], confirming the accuracy of ARIBA for identifying known resistance SNPs as well as the presence or absence of genes of interest.
The phenotypic resistance profile for a number of antimicrobials is known for each isolate, and is attributable to both acquired resistance genes and SNPs. The three tools were run on all 130 samples using the reference database from CARD, version 1.1.2. To ensure our results were comparable with those originally reported in Table S1 of Holt et al. [24 (link)], we manually added those AMR genes listed on page 4 of their supplementary text not already included in the database (Table S3). The AMR determinants originally reported in the study of Holt et al. [24 (link)] were identified from mapping data, and reported as the proportion of bases in the gene sequence that were covered by reads from each isolate. From these originally reported data, we used a cut-off of >90 % to indicate that a gene was present by their method.
In order to interpret the output of each tool as an AMR call, the following rules were used, where all relevant genes are listed in Table S4. A gene was counted as present by ARIBA if ariba summary reported yes or yes_nonunique; present by KmerResistance if it appeared in its output file; and present by SRST2 if it was reported without a ‘?’.
The focus for the genes of interest for each AMR call were those originally identified and reported in Holt et al. [24 (link)]. Given that the discovery and classification of AMR gene variants is an ongoing process, an AMR gene was called as present if it was either the originally identified gene in Holt et al. [24 (link)], or in the same CD-HIT cluster. Genes conferring resistance to antimicrobials not examined in the original paper were excluded, as were genes conferring resistance to the antimicrobials examined in the paper but falling in different CD-HIT clusters from the originally identified genes. For each antimicrobial examined, an AMR call for a resistant genotype was identified using the following rules. Ampicillin (Amp): the presence of any gene from a set of blaTEM, blaCTX-M and blaOXA genes. Chloramphenicol (Cmp): the presence of any gene from a set of cat genes. Nalidixic acid (Nal): the gyrA gene present, together with one of the SNPs S83L, D87G, or D87Y. Streptomycin (Str): both of the strA and strB genes, or one of the aadA genes. Sulfonamides (Sul): any gene from the set of sul1 and sul2 genes. Tetracycline (Tet): both of tetA +tetR, or all of tetA, C, D, R, where each of the two sets of tetA and tetR genes are disjoint. Trimethoprim (Tmp): any one of a set of dfrA or dhfr genes.
Full text: Click here
Publication 2017
4,4-difluororetinoic acid Ampicillin Chloramphenicol Drug Resistance, Microbial Dysentery Gene Clusters Genes Genetic Diversity Genome Genotype Gram Negative Bacteria Microbicides Nalidixic Acid Phenotype Shigella sonnei Single Nucleotide Polymorphism Streptomycin Sulfonamides Tetracycline Trientine Trimethoprim

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2013
Ampicillin Arabinose Cell Culture Techniques Cells Chloramphenicol Cloning Vectors Electroporation Escherichia coli Genes Genes, Reporter Genome Insertion Mutation Inverse PCR Kanamycin Plasmids Proteins Recombination, Genetic Replication Origin Strains Transcription Initiation Site

E. coli K-12 BW25113 carrying the Red helper plasmid pKD46 was grown in 100 ml SOB medium with ampicillin and 1 mM L-arabinose at 30°C to an OD600 of 0.3, and electroporation-competent cells were prepared as described elsewhere (Sambrook et al, 1998 ). A measure of 50 μl of competent cells was mixed with 400 ng of the PCR fragment in an ice-cold 0.2 cm cuvette (Bio-Rad Inc.). Cells were electroporated at 2.5 kV with 25 mF and 200 Ω, immediately followed by the addition of 1 ml of SOC medium (2% Bacto Tryptone (Difco), 0.5% yeast extract (Difco), 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4, 20 mM glucose) with 1 mM L-arabinose. After incubation for 2 h at 37°C, one-tenth portion was spread onto agar plate to select KmR transformants at 37°C.
Publication 2006
Agar Ampicillin Arabinose Cells Cold Temperature Electroporation Escherichia coli Glucose Magnesium Chloride Plasmids Sodium Chloride Sulfate, Magnesium Yeast, Dried
The Luria-Bertani (LB) media (10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl) is obtained from Fisher Scientific (Pittsburgh, PA). The supplemented minimal media contains M9 minimal salts (6.8 g/L Na2PO4, 3 g/L KH2PO4, 0.5 g/L NaCl, 1 g/L NH4Cl) from Sigma, 2 mM MgSO4 (Fischer Scientific), 100 μM CaCl2 (Fischer Scientific), 0.4% glucose (Sigma), 0.05 g/L leucine (Acros Organics, Belgium), 5 μg/mL chloramphenicol (Acros Organics), and an adjusted pH of 7.4. The expression system is a ColE1 vector with chloramphenicol resistance (derived from pProTet, Clontech). The expression cassette contains a σ70 constitutive promoter (BioBrick J23100), the RBS sequence, followed by the mRFP1 fluorescent protein reporter. XbaI and SacI restriction sites are located before the RBS and after the start codon. An RBS with a desired sequence is inserted into the expression vector using standard cloning techniques. Pairs of complementary oligonucleotides are designed with XbaI and SacI overhangs and the vector is digested with XbaI and SacI restriction enzymes (NEB, Ipswich, MA). Ligation of the annealed oligonucleotides with cut vector results in a nicked plasmid, which is transformed into E. coli DH10B cells. Sequencing is used to verify a correct clone.
The AND gate genetic circuit is composed of three plasmids: pBACr-AraT7940, pBR939b, and pAC-SalSer914 with kanamycin, ampicillin, and chloramphenicol resistance markers, respectively. The PBAD promoter maximum expression level was modified by inserting designed synthetic RBSs on plasmid pBACr-AraT7940. Plasmid pBACr-AraT7940 was digested with BamHI and ApaLI enzymes and pairs of oligonucleotides were designed to contain the desired RBS sequence and corresponding overhangs. Ligation, transformation, selection, and sequencing proceeded as described above.
Publication 2009
Ampicillin Cells Chloramphenicol Chloramphenicol Resistance Clone Cells Cloning Vectors Codon, Initiator DNA Restriction Enzymes Enzymes Escherichia coli Gene Circuits Glucose Kanamycin Leucine Ligation Mrfp1 protein Oligonucleotides Plasmids Saccharomyces cerevisiae Salts Sodium Chloride Sulfate, Magnesium

Most recents protocols related to «Ampicillin»

Example 6

TbpB and NMB0313 genes were amplified from the genome of Neisseria meningitidis serotype B strain B16B6. The LbpB gene was amplified from Neisseria meningitidis serotype B strain MC58. Full length TbpB was inserted into Multiple Cloning Site 2 of pETDuet using restriction free cloning ((F van den Ent, J. Löwe, Journal of Biochemical and Biophysical Methods (Jan. 1, 2006)).). NMB0313 was inserted into pET26, where the native signal peptide was replaced by that of pelB. Mutations and truncations were performed on these vectors using site directed mutagenesis and restriction free cloning, respectively. Pairs of vectors were transformed into E. coli C43 and were grown overnight in LB agar plates supplemented with kanamycin (50 μg/mL) and ampicillin (100 μg/mL).

tbpB genes were amplified from the genomes of M. catarrhalis strain 035E and H. influenzae strain 86-028NP and cloned into the pET52b plasmid by restriction free cloning as above. The corresponding SLAMs (M. catarrhalis SLAM 1, H. influenzae SLAM1) were inserted into pET26b also using restriction free cloning. A 6His-tag was inserted between the pelB and the mature SLAM sequences as above. Vectors were transformed into E. coli C43 as above.

Cells were harvested by centrifugation at 4000 g and were twice washed with 1 mL PBS to remove any remaining growth media. Cells were then incubated with either 0.05-0.1 mg/mL biotinylated human transferrin (Sigma-aldrich T3915-5 MG), α-TbpB (1:200 dilution from rabbit serum for M. catarrhalis and H. influenzae; 1:10000 dilution from rabbit serum for N. meningitidis), or α-LbpB (1:10000 dilution from rabbit serum-obtained a gift from J. Lemieux) or α-fHbp (1:5000 dilution from mouse, a gift from D. Granoff) for 1.5 hours at 4° C., followed by two washes with 1 mL of PBS. The cells were then incubated with R-Phycoerythrin-conjugated Streptavidin (0.5 mg/ml Cedarlane) or R-phycoerythrin conjugated Anti-rabbit IgG (Stock 0.5 mg/ml Rockland) at 25 ug/mL for 1.5 hours at 4° C. The cells were then washed with 1 mL PBS and resuspended in 200 uL fixing solution (PBS+2% formaldehyde) and left for 20 minutes. Finally, cells were washed with 2×1 mL PBS and transferred to 5 mL polystyrene FACS tubes. The PE fluorescence of each sample was measured for PE fluorescence using a Becton Dickinson FACSCalibur. The results were analyzed using FLOWJO software and were presented as mean fluorescence intensity (MFI) for each sample. For N. meningtidis experiments, all samples were compared to wildtype strains by normalizing wildtype fluorescent signals to 100%. Errors bars represent the standard error of the mean (SEM) across three experiments. Results were plotted statistically analysed using GraphPad Prism 5 software. The results shown in FIG. 6 for the SLPs, TbpB (FIG. 6A), LbpB. (FIG. 6B) and fHbp (FIG. 6C) demonstrate that SLAM effects translocation of all three SLP polypeptides in E. coli. The results shown in FIG. 10 demonstrate that translocation of TbpB from M. catarrhalis (FIG. 10C) and in H. influenzae (FIG. 10D) in E. coli require the co-expression of the required SLAM protein (Slam is an outer membrane protein that is required for the surface display of lipidated virulence factors in Neisseria. Hooda Y, Lai C C, Judd A, Buckwalter C M, Shin H E, Gray-Owen S D, Moraes T F. Nat Microbiol. 2016 Feb. 29; 1:16009).

Full text: Click here
Patent 2024
ADRB2 protein, human Agar Ampicillin anti-IgG Cells Centrifugation Cloning Vectors Culture Media Escherichia coli Fluorescence Formaldehyde Genes Genome Haemophilus influenzae Homo sapiens Kanamycin Lipoproteins Membrane Proteins Moraxella catarrhalis Mus Mutagenesis, Site-Directed Mutation Neisseria Neisseria meningitidis Phycoerythrin Plasmids Polypeptides Polystyrenes prisma Rabbits Serum Signaling Lymphocytic Activation Molecule Family Member 1 Signal Peptides Strains Streptavidin Technique, Dilution Transferrin Translocation, Chromosomal Virulence Factors

Example 8

In selecting genomes for a given bacterial species where a SLAM homolog was identified, preference was given to reference genomes that contained fully sequenced genomes. SLAM homologs were identified using iterative Blast searches into closely related species to Neisseria to more distantly related species. For each of the SLAM homologs identified in these species, the corresponding genomic record (NCBI genome) was used to identify genes upstream and downstream along with their corresponding functional annotations (NCBI protein database, Ensembl bacteria). In a few cases, no genes were predicted upstream or downstream of the SLAM gene as they were too close to the beginning or end of the contig, respectively, and thus these sequences were ignored.

Neighbouring genes were analyzed for 1) an N-terminal lipobox motif (predicted using LipoP, SignalP), and 2) a solute binding protein, Tbp-like (InterPro signature: IPR or IPR011250), or pagP-beta barrel (InterPro signature: IPR011250) fold. If they contained these elements, we identified the adjacent genes as potential SLAM-dependent surface lipoproteins.

A putative SLAM (PM1515, SEQ ID NO: 1087) was identified in Pasteurella multocida using the Neisseria SLAM as a search. The putative SLAM (PM1515, SEQ ID NO: 1087) was adjacent to a newly predicted lipoprotein gene with unknown function (PM1514, SEQ ID NO: 1083) (FIG. 11A). The putative SLAM displayed 32% identity to N. meningitidis SLAM1 while the SLP showed no sequence similarity to known SLAM-dependent neisserial SLPs.

The putative SLAM (PM1515, SEQ ID NO: 1087) and its adjacent lipoprotein (PM1514, SEQ ID NO: 1083) were cloned into pET26b and pET52b, respectively, as previously described and transformed into E. coli C43 and grown overnight on LB agar supplemented with kanamycin (50 ug/ml) and ampicillin (100 ug/ml).

Cells were grown in auto-induction media for 18 hours at 37 C and then harvested, washed twice in PBS containing 1 mM MgCl2, and labeled with α-Flag (1:200, Sigma) for 1 hr at 4 C. The cells were then washed twice with PBS containing 1 mM MgCl2 and then labeled with R-PE conjugated α-mouse IgG (25 ug/mL, Thermo Fisher Scientific) for 1 hr at 4 C. following straining, cells were fixed in 2% formaldehyde for 20 minutes and further washed with PBS containing 1 mM MgCl2. Flow Cytometry was performed with a Becton Dickinson FACSCalibur and the results were analyzed using FLOWJO software. Mean fluorescence intensity (MFI) was calculated using at least three replicates was used to compare surface exposure the lipoprotein in strains either containing or lacking the putative SLAM (PM1515) and are shown in FIG. 11C and FIG. 11D. PM1514 could be detected on the surface of E. coli illustrating i) that SLAM can be used to identify SLPs and ii) that SLAM is required to translocate these SLPs to the surface of the cell—thus identifying a class of proteins call “SLAM-dependent surface lipoproteins”. Antibodies were raised against purified PmSLP (PM1514) and the protein was shown to be on the surface of Pasteurella multocida via PK shaving assays.

Full text: Click here
Patent 2024
Agar Ampicillin Antibodies Bacteria Binding Proteins Biological Assay Cells Escherichia coli Flow Cytometry Fluorescence Formaldehyde Genes Genome Kanamycin Lipoprotein (a-) Lipoproteins Magnesium Chloride Mus Neisseria Neisseria meningitidis Pasteurella multocida Proteins Staphylococcal Protein A Strains
Not available on PMC !

Example 2

Recombinant human fascin 1 was expressed as a GST fusion protein in BL21 Escherichia coli. One liter of 2YT medium with ampicillin was inoculated overnight with 3 mL of BL21/DE3 culture transformed with pGEX4T-fascin 1 plasmid and grown at 37° C. until attenuance at 600 nm (D600) reached about 0.8. The culture was then transferred to 18° C. and induced by the addition of 0.1 mM isopropyl β-d-thiogalactoside (IPTG) for 12 h. Bacteria were harvested by centrifugation at 5,000 r.p.m. for 10 min. The pellets were suspended in 30 mL of PBS supplemented with 0.2 mM PMSF, 1 mM DTT, 1% (v/v) Triton X-100 and 1 mM EDTA. After sonication, the suspension was centrifuged at 15,000 r.p.m. for 30 min to remove the cell debris. The supernatant was then incubated for 2 h with 4 mL of glutathione beads (Sigma) at 4° C. After extensive washing with PBS, the beads were resuspended in 10 mL of thrombin cleavage buffer (20 mM Tris-HCl pH 8.0, 150 mM NaCl, 2 mM CaCl2, 1 mM DTT). Fascin was released from the beads by incubation overnight with 40-100 U of thrombin at 4° C. After centrifugation, 0.2 mM PMSF was added to the supernatant to inactivate the remnant thrombin activity. The fascin protein was further concentrated with a Centricon® (Boca Raton, FL) filter to about 50 mg/mL.

Full text: Click here
Patent 2024
Ampicillin Bacteria Brown Oculocutaneous Albinism Buffers Cells Centrifugation Cytokinesis D-600 Edetic Acid Escherichia coli fascin Glutathione Homo sapiens Isopropyl Thiogalactoside Pellets, Drug Plasmids Proteins Sodium Chloride Staphylococcal Protein A Thrombin Triton X-100 Tromethamine
Not available on PMC !

Example 2

Recombinant human fascin 1 was expressed as a GST fusion protein in BL21 Escherichia coli. One liter of 2YT medium with ampicillin was inoculated overnight with 3 mL of BL21/DE3 culture transformed with pGEX4T-fascin 1 plasmid and grown at 37° C. until attenuance at 600 nm (D600) reached about 0.8. The culture was then transferred to 18° C. and induced by the addition of 0.1 mM isopropyl β-d-thiogalactoside (IPTG) for 12 h. Bacteria were harvested by centrifugation at 5,000 r.p.m. for 10 min. The pellets were suspended in 30 mL of PBS supplemented with 0.2 mM PMSF, 1 mM DTT, 1% (v/v) Triton X-100 and 1 mM EDTA. After sonication, the suspension was centrifuged at 15,000 r.p.m. for 30 min to remove the cell debris. The supernatant was then incubated for 2 h with 4 mL of glutathione beads (Sigma) at 4° C. After extensive washing with PBS, the beads were resuspended in 10 mL of thrombin cleavage buffer (20 mM Tris-HCl pH 8.0, 150 mM NaCl, 2 mM CaCl2), 1 mM DTT). Fascin was released from the beads by incubation overnight with 40-100 U of thrombin at 4° C. After centrifugation, 0.2 mM PMSF was added to the supernatant to inactivate the remnant thrombin activity. The fascin protein was further concentrated with a Centricon® (Boca Raton, FL) filter to about 50 mg/mL.

Full text: Click here
Patent 2024
Ampicillin Bacteria Brown Oculocutaneous Albinism Buffers Cells Centrifugation Cytokinesis D-600 Edetic Acid Escherichia coli fascin Glutathione Homo sapiens Isopropyl Thiogalactoside Pellets, Drug Plasmids Proteins Sodium Chloride Staphylococcal Protein A Thrombin Triton X-100 Tromethamine

Example 1

This example describes the generation of a marker-free B. subtilis strain expressing allulose epimerase. Briefly, in a first step, a B. subtilis strain was transformed with a cassette encoding the BMCGD1 epimerase and including an antibiotic resistance marker. This cassette recombined into the Bacillus chromosome and knocked out 8 kb of DNA, including a large sporulation gene cluster and the lysine biosynthesis gene lysA. In a second step, a second cassette was recombined into the B. subtilis chromosome, restoring the lysA gene and removing DNA encoding the antibiotic resistance. E. coli strain 39 A10 from the Keio collection was used to passage plasmid DNA prior to transformation of B. subtilis. The relevant phenotype is a deficiency in the DNA methylase HsdM in an otherwise wild-type K-12 strain of E. coli.

In detail, a cassette of 5120 bp (SEQ ID NO:1; synthetic DNA from IDT, Coralville, Iowa) was synthesized and cloned into a standard ampicillin resistant pIDT vector. The synthetic piece encoded 700 bp upstream of lysA on the B. subtilis chromosome, the antibiotic marker cat (651 bp), the DNA-binding protein lad (1083 bp), and the allulose epimerase (894 bp), and included 700 bp of homology in dacF. This vector was transformed into E. coli strain 39 A10 (Baba et al., 2006), and plasmid DNA was prepared and transformed into B. subtilis strains 1A751 and 1A976.

Transformants were selected on LB supplemented with chloramphenicol. The replicon for pIDT is functional in E. coli but does not work in Gram positive bacteria such as B. subtilis. The colonies that arose therefore represented an integration event into the chromosome. In strain 1A751, the colony morphology on the plates was used to distinguish between single and double recombination events. The double recombination event would knock out genes required for sporulation, whereas the single recombination would not. After three days on LB plates, colonies capable of sporulation were brown and opaque; sporulation-deficient colonies were more translucent.

B. subtilis strain 1A976 with the allulose epimerase cassette is auxotrophic for histidine and lysine and can achieve very high transformation efficiency upon xylose induction. A 1925 bp synthetic DNA (SEQ ID NO:2) was amplified by primers (SEQ ID NO:3, SEQ ID NO:4) and Taq polymerase (Promega). This PCR product encoded the lysA gene that was deleted by the dropping in the epimerase cassette and 500 bp of homology to lad. A successful double recombination event of this DNA should result in colonies that are prototrophic for lysine and sensitive to chloramphenicol; i.e., the entire cat gene should be lost.

Transformants were selected on Davis minimal media supplemented with histidine. Colonies that arose were characterized by PCR and streaking onto LB with and without chloramphenicol. Strains that amplified the introduced DNA and that were chloramphenicol sensitive were further characterized, and their chromosomal DNA was extracted.

Strain 1A751 containing the chloramphenicol resistant allulose was transformed with this chromosomal DNA and selected on Davis minimal media supplemented with histidine. Transformants were streaked onto LB with and without chloramphenicol and characterized enzymatically as described below.

Full text: Click here
Patent 2024
Ampicillin Anabolism Antibiotic Resistance, Microbial Antibiotics Bacillus Bacillus subtilis Chloramphenicol Chromosomes Cloning Vectors DNA, A-Form DNA-Binding Proteins Epimerases Escherichia coli Gene Clusters Gene Knockout Techniques Genes Gram-Positive Bacteria Histidine Lysine Methyltransferase Oligonucleotide Primers Phenotype Plasmids psicose Recombination, Genetic Replicon Strains Taq Polymerase Xylose

Top products related to «Ampicillin»

Sourced in United States, Germany, United Kingdom, France, China, Switzerland, Sao Tome and Principe, Spain, Ireland, India, Italy, Japan, Brazil, Australia, Canada, Macao, Czechia, New Zealand, Belgium, Cameroon, Austria, Israel, Norway, Denmark, Netherlands
Ampicillin is a broad-spectrum antibiotic used in laboratory settings. It is a penicillin-based compound effective against a variety of gram-positive and gram-negative bacteria. Ampicillin functions by inhibiting cell wall synthesis, leading to bacterial cell lysis and death.
Sourced in United Kingdom, United States, China, Germany, Belgium, Italy, Australia
Ampicillin is an antibiotic that is commonly used in microbiology and molecular biology laboratories. It is a broad-spectrum penicillin-type antibiotic that inhibits the synthesis of bacterial cell walls, effectively killing or preventing the growth of susceptible bacteria.
Sourced in United States, Germany, United Kingdom, France, Spain, China, Israel, India, Canada, Macao, Australia, Sao Tome and Principe, Belgium, Sweden, Poland, Japan, Switzerland, Brazil, Italy, Ireland
Kanamycin is a broad-spectrum antibiotic derived from the bacterium Streptomyces kanamyceticus. It is commonly used as a selective agent in molecular biology and microbiology laboratories for the growth and selection of bacteria that have been genetically modified to express a gene of interest.
Sourced in United States, Germany, France, United Kingdom, Italy, China, Australia, Israel, Switzerland, Spain, India, Sao Tome and Principe, Brazil, Canada, Belgium, Czechia, Mexico, Poland, Ireland
Chloramphenicol is a bacteriostatic antibiotic that inhibits protein synthesis in bacteria. It is commonly used in microbiology laboratories for selective cultivation and identification of bacterial species.
Sourced in United States, Germany, United Kingdom, Italy, Sao Tome and Principe, Spain, India, Switzerland, Belgium, Sweden, Ireland, France, China, Japan, Australia
Vancomycin is a laboratory product manufactured by Merck Group. It is an antibiotic used for the detection and quantification of Vancomycin-resistant enterococci (VRE) in clinical samples.
Sourced in United States, Germany, United Kingdom, China, India, Japan, Switzerland, Spain, Australia, Czechia, Sao Tome and Principe, Brazil
Metronidazole is a synthetic antimicrobial agent. It is a white to pale yellow crystalline powder that is slightly soluble in water and freely soluble in alcohol, acetone, and dimethyl sulfoxide. Metronidazole can be used as a reference standard or in the manufacture of pharmaceutical preparations.
Sourced in United States, Germany, United Kingdom, China, Spain, Macao, Belgium
Neomycin is an antibiotic medication produced by the Merck Group. It is a type of aminoglycoside antibiotic that functions by inhibiting protein synthesis in bacterial cells.
Sourced in United States, Germany, United Kingdom, Italy, France, China, Macao, Poland, Switzerland, Spain, Sao Tome and Principe, Japan, Brazil, Canada, Australia, Belgium, Austria, Netherlands, Israel, India, Sweden, Denmark, Ireland, Czechia, Norway, Gabon, Argentina, Portugal, Hungary, Holy See (Vatican City State), Mexico, Ukraine, Slovakia
Streptomycin is a laboratory product manufactured by Merck Group. It is an antibiotic used in research applications.
Sourced in United States, Germany, United Kingdom, France, Australia, Italy, China, Switzerland, Denmark, India, Czechia, Poland, Sao Tome and Principe, Japan, Sweden
Tetracycline is a type of antibiotic used for laboratory testing and research. It is a broad-spectrum antimicrobial agent effective against a variety of bacteria. Tetracycline is commonly used in microbiological studies and antimicrobial susceptibility testing.
Sourced in Germany, United States, United Kingdom, Spain, Netherlands, Canada, Japan, France, Norway, China, Switzerland, Denmark, Australia, Italy
The QIAprep Spin Miniprep Kit is a laboratory product designed for the rapid and efficient purification of plasmid DNA from bacterial cultures. It is a versatile tool used in various molecular biology applications.

More about "Ampicillin"

Ampicilln, amp, penicillin, antibiotic, gram-positive, gram-negative, pneumonia, meningitis, gonorrhea, UTI, urinary tract infection, cell wall, lysis, PubCompare.ai, reproducibility, accuracy, protocols, preprints, patents, Kanamycin, Chloramphenicol, Vancomycin, Metronidazole, Neomycin, Streptomycin, Tetracycline, QIAprep Spin Miniprep Kit